Suppressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded at the trigeminal spinal tract nucleus in cats

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 3, 2001, Pages 169-175

  Kiguchi, Sumiyoshi ^a   Ichikawa, Kiyoshi ^a   Kojima, Masami ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Carbamazepine; Maxillary canine tooth pulp; Nociception; Oxcarbazepine; Trigeminal spinal tract nucleus

Indexed keywords

10,11 DIHYDRO 10 HYDROXY 5H DIBENZ[B,F]AZEPINE 5 CARBOXAMIDE; AMIDE; CARBAMAZEPINE; MEXILETINE; MORPHINE; OXCARBAZEPINE; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED RESPONSE; NERVE CELL; NERVE CONDUCTION; NOCICEPTION; NONHUMAN; PAIN; TOOTH PULP; TRIGEMINAL NUCLEUS;

ANALGESICS, OPIOID; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; CARBAMAZEPINE; CATS; DENTAL PULP; DIBENZAZEPINES; ELECTRIC STIMULATION; EVOKED POTENTIALS; FEMALE; MALE; MEXILETINE; MICROINJECTIONS; MORPHINE; POLYETHYLENE GLYCOLS; SYNAPTIC TRANSMISSION; TRIGEMINAL NUCLEUS, SPINAL;

EID: 0035124481     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03431.x     Document Type: Article

References (22)

1. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: Lidocaine, carbamazepine, and mexiletine
2. Trigeminal neuralgia: Its treatment with a new anticonvulsant drug (G32883)
3. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
4. Oxcarbazepine: Clinical development program
5. C-Fiber activity in feline tooth pulp afferents
6. A quantitative analysis of the innervation of the pulp of the cat's canine tooth
7. Differential distribution of four types of tooth pulp neurones in the caudal medulla oblongata of the cat
8. Tooth pulp-evoked potentials in the trigeminal brainstem nuclear complex
9. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis
10. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene
11. Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of distribution following intravenous, intracerebral, and intraventricular application
12. Analgesia nediated by a direct spinal action of narcotics
13. Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter
14. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats
15. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters
16. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures
17. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure
18. Trigeminothalamic neurons in nucleus caudalis responsive to tactile, thermal, and nociceptive stimulation of monkey's face
19. Antinociceptive effect of KIN-493 in animal models
20. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla
21. Trigeminal neuralgia: Its tratment with two new carbamazepine analogues
22. Oxcarbazepine: New drug in the management of intractable trigeminal neuralgia